Design, synthesis, and characterization of non-hemolytic antimicrobial peptides related to human cathelicidin LL-37
被引:5
|
作者:
Krishnamoorthy, Rajavenkatesh
论文数: 0引用数: 0
h-index: 0
机构:
CSIR CLRI, Organ & Bioorgan Chem Lab, Chennai 600020, Tamil Nadu, India
Sethu Inst Technol, Dept Chem, Virudunagar 626115, Tamil Nadu, IndiaCSIR CLRI, Organ & Bioorgan Chem Lab, Chennai 600020, Tamil Nadu, India
Krishnamoorthy, Rajavenkatesh
[1
,2
]
论文数: 引用数:
h-index:
机构:
Adhikari, Priyanka
[3
]
Anaikutti, Parthiban
论文数: 0引用数: 0
h-index: 0
机构:
Natl Inst Pharmaceut Educ & Res, Ctr GMP Extract Facil, Dept Biotechnol, Gauhati 781101, Assam, IndiaCSIR CLRI, Organ & Bioorgan Chem Lab, Chennai 600020, Tamil Nadu, India
Anaikutti, Parthiban
[3
]
机构:
[1] CSIR CLRI, Organ & Bioorgan Chem Lab, Chennai 600020, Tamil Nadu, India
[2] Sethu Inst Technol, Dept Chem, Virudunagar 626115, Tamil Nadu, India
We designed and synthesised the N-terminally labeled cationic and hydrophobic peptides, i.e., FFKKSKEKIGKEFKKIVQKI (P1) and FRRSRERIGREFRRIVQRI (P2) related to the human cathelicidin LL-37 peptide. The integrity and molecular weight of the peptides were confirmed by mass spectrometry. The purity and homogeneity of peptides P1 and P2 were determined by comparing LCMS or analytical HPLC chromatograms. The circular dichroism spectroscopy reveals the conformational transitions upon interaction with membranes. Predictably, peptides P1 and P2 showed a random coil structure in the buffer and formed alpha-helix secondary structure in TFE and SDS micelles. This assessment was further confirmed by 2D NMR spectroscopic methods. The analytical HPLC binding assay measurements revealed that peptides P1 and P2 display preferential interactions with the anionic lipid bilayer (POPC:POPG) moderately than zwitterionic (POPC). The efficacies of the peptides were tested against Gram-positive and Gram-negative bacteria. It is imperative to note here that the arginine-rich P2 exerted higher activity against all the test organisms as compared with that shown by the lysine-rich peptide P1. To test the toxicity of these peptides, a hemolytic assay was performed. P1 and P2 showed very little to no toxicity for a hemolytic assay, which is significant for P1 and P2 to be used as potential therapeutic agents in practical applications. Both peptides P1 and P2 were non-hemolytic and appeared to be more promising as they demonstrated wide-spectrum antimicrobial activity.